Keros Therapeutics, Inc. ($KROS)
Regnante Keith โ CHIEF FINANCIAL OFFICER
Shares
4,739
Price
$16.35
Total Value
$77,482.65
Nearby Earnings
Feb 25, 2026
EPS:Est: -0.49
Transaction Details
| Insider | Regnante Keith |
|---|---|
| Title | CHIEF FINANCIAL OFFICER |
| Transaction Date | Feb 18, 2026 |
| Transaction Code | S Sale |
| Acquired/Disposed | Disposed |
| Security | Common Stock |
| Direct/Indirect | Direct |
| Filing Date | Feb 20, 2026 |
| Shares Sold | 4,739 |
| Price per Share | $16.35 |
| Total Value | $77,482.65 |
| Shares Owned After | 39,261 |
| Derivative | No |
| Accession Number | 0001682068-26-000003 |
| Document | View SEC Filing |